Shihong Wei
Overview
Explore the profile of Shihong Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tseng I, Chen Y, Ai D, Zhu Z, Zhao W, Fan M, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40053692
Purpose: Preclinical model found that elective nodal irradiation (ENI) attenuated the efficacy of radiotherapy and radio-immunotherapy. However, limited clinical studies have explored the correlation between radiation dose-volume parameters of negative...
2.
Shao L, Dong Y, Jiang M, Song H, Qi Y, Guo L, et al.
Oncol Lett
. 2025 Jan;
29(3):123.
PMID: 39807106
The role of prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer (LS-SCLC) remains controversial in the era of magnetic resonance imaging (MRI). The present study aimed to...
3.
Sun H, Li M, Huang W, Zhang J, Wei S, Yang Y, et al.
J Clin Oncol
. 2024 Oct;
43(4):412-421.
PMID: 39374473
Purpose: This multicenter, randomized, phase III clinical trial (Northern Radiation Oncology Group of China-002) focused on patients with oligo-organ metastatic non-small cell lung cancer (NSCLC) who have epidermal growth factor...
4.
Chen Y, Tang S, Hameed M, Wang Q, Xu X, Bao J, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Sep;
325:125075.
PMID: 39236569
Alzheimer's disease (AD), characterized by its incurable nature and prevalence among the elderly, has remained a focal point in medical research. Increasing evidence suggests that peroxynitrite (ONOO) serves as a...
5.
Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et al.
Nat Med
. 2024 Jul;
30(10):2967-2976.
PMID: 38992123
Immunochemotherapy is the first-line standard for extensive-stage small-cell lung cancer (ES-SCLC). Combining the regimen with anti-angiogenesis may improve efficacy. ETER701 was a multicenter, double-blind, randomized, placebo-controlled phase 3 trial that...
6.
Zhong D, Wei S, Zhou H, He X, Qian B, Ma B, et al.
Materials (Basel)
. 2024 Jun;
17(11).
PMID: 38893835
In this paper, the possibility of retreated lithium slag (RTLS) with a high content of alkali, sulfate and fluoride as a partial replacement for fly ash (FA) to produce autoclaved...
7.
Guo L, Dong Y, Qi Y, Tao N, Song H, Shao L, et al.
Altern Ther Health Med
. 2024 May;
PMID: 38814604
Objective: To investigate the risk factors for lung infection in lung cancer patients undergoing radiotherapy. Methods: We selected 142 patients with lung cancer who underwent radiotherapy at our hospital from...
8.
Guo L, Qi Y, Tao N, Dong Y, Song H, Shao L, et al.
Panminerva Med
. 2023 Dec;
66(2):233-235.
PMID: 38093627
No abstract available.
9.
Liu Q, Chen J, Lin Y, Ye J, Shen W, Luo H, et al.
Lancet Gastroenterol Hepatol
. 2023 Nov;
9(1):45-55.
PMID: 37980921
Background: The efficacy of local therapy for patients with oligometastatic oesophageal squamous cell carcinoma is unclear. We aimed to assess the efficacy of local plus systemic therapy compared with systemic...
10.
Li H, Huang Y, Chen Z, Zeng A, Zhang H, Yu Y, et al.
BioDrugs
. 2023 Feb;
37(2):259-269.
PMID: 36802320
Background: Denosumab has been approved for the treatment of bone metastases from solid tumors. QL1206 is the first denosumab biosimilar and needs to be compared with denosumab in a phase...